M&A Deal Summary

Genesis Biotechnology Group Acquires 4path

On August 3, 2017, Genesis Biotechnology Group acquired healthcare services company 4path

Acquisition Highlights
  • This is Genesis Biotechnology Group’s 1st transaction in the Healthcare Services sector.
  • This is Genesis Biotechnology Group’s 2nd transaction in the United States.
  • This is Genesis Biotechnology Group’s 1st transaction in Illinois.

M&A Deal Summary
Date 2017-08-03
Target 4path
Sector Healthcare Services
Buyer(s) Genesis Biotechnology Group
Deal Type Add-on Acquisition

Target

4path

Burr Ridge, Illinois, United States
4path Ltd. is a provider of highly personalized diagnostic services with expertise in Podiatry, Gastroenterology, Urology, Dermatology, Breast, Gynecology, Orthopedics and other specialties. 4path is based in Burr Ridge, Illinois.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Genesis Biotechnology Group

Hamilton, New Jersey, United States
Category Company
Sector Life Science
DESCRIPTION

Genesis Biotechnology Group is a consortium of vertically integrated corporate research entities, which facilitates the overall market implementation and delivery of biomedical science products and services related to diagnostics and drug discovery.

DEAL STATS #
Overall 2 of 5
Sector (Healthcare Services) 1 of 1
Type (Add-on Acquisition) 2 of 5
State (Illinois) 1 of 1
Country (United States) 2 of 5
Year (2017) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-03-01 PharmOptima

Portage, Michigan, United States

PharmOptima LLC is a drug discovery and development in various therapeutic areas and has filled a niche in ocular drug development.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-08-05 Comparative Biosciences

Sunnyvale, California, United States

Comparative Biosciences, Inc. is specialized in GLP (Good Laboratory Practice) Toxicology and Safety Pharmacology projects for IND-enabling research studies. This portfolio addition will enable GD3 to expand its pre-clinical services to GLP based studies by (1) offering integrated, single-point-of-contact services throughout the project lifetime, (2) streamlining all phases of the discovery cycle and (3) enabling new discoveries to progress rapidly from project inception through pre-clinical development. Comparative Biosciences was founded in 1996 and is based in Sunnyvale, California.

Buy -
Mergr

Product

Company

Legal